FAIR VALUE MEASUREMENTS (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

The following table presents information about the fair value measurement of the Company’s financial instruments (in thousands):

		As of December 31,
Financial Instruments Recorded at Fair Value on a Recurring Basis:	Fair Value Measurement Level	2022		2021
Assets:
Derivative assets—foreign currency contracts (1)	2	$	—	$	1,439
Derivative assets—interest rate swap contract (2)	2	23,410		—
Total assets		$	23,410	$	1,439
Liabilities:
Derivative liabilities—foreign currency contracts (3)	2	$	1,001	$	—
Contingent consideration—earn out (4)	3	22,747		25,300
Total liabilities		$	23,748	$	25,300

(1)Included in prepaid expenses and other current assets in the consolidated balance sheets

(2)Included in prepaid expenses and other current assets and other non-current assets in the consolidated balance sheets

(3)Included in other current liabilities in the consolidated balance sheets

(4)Included in current and non-current contingent consideration in the consolidated balance sheets

Schedule of Fair Value Contingent Consideration

The following table presents the fair value of contingent consideration (in thousands):

Balance at December 31, 2021	$	25,300
Payments of contingent consideration	(12,555)
Adjustments to fair value of contingent consideration	10,002
Balance at December 31, 2022	$	22,747

Schedule of Financial Instruments Recorded at Carrying Amount

The following financial instruments are recorded at their carrying amount (in thousands):

	As of December 31, 2022				As of December 31, 2021
Financial Instruments Recorded at Carrying Amount:	Carrying Amount		Estimated Fair Value		Carrying Amount		Estimated Fair Value
Liabilities:
Debt—Credit Facilities (1)	$	476,070	$	393,236	$	388,195	$	386,139
Total liabilities	$	476,070	$	393,236	$	388,195	$	386,139

(1)Included in the current portion of notes payable and notes payable, net of current portion in the consolidated balance sheets. Due to the unobservable nature of the inputs these financial instruments are considered to be Level 3 instruments in the fair value hierarchy